A double-blind placebo controlled study of inhaled Zanamivir for the treatment and prevention of influenza in families had a 79% efficacy in preventing secondary cases when drug was given for 10 days to all exposed family members.
Reference:
Add information to this page that would be handy to have on hand during a consultation, such as a web address or phone number. This information will always be displayed when you visit this page